IOL Chemicals and Pharmaceuticals Submits Q4FY26 SDD Compliance Certificate to Stock Exchanges
IOL Chemicals and Pharmaceuticals Limited filed its Q4FY26 SDD compliance certificate with NSE and BSE on 17th April 2026, confirming full adherence to SEBI's Prohibition of Insider Trading Regulations. The company achieved 100% compliance by capturing 1 out of 1 required events during the quarter with no non-compliance issues reported, demonstrating robust corporate governance and regulatory adherence.

*this image is generated using AI for illustrative purposes only.
IOL Chemicals & Pharmaceuticals Limited has submitted its quarterly compliance certificate for Structured Digital Database (SDD) to both the National Stock Exchange of India and BSE Limited on 17th April 2026. The certificate pertains to the quarter ended 31st March 2026 and demonstrates the company's adherence to regulatory requirements under SEBI's Prohibition of Insider Trading Regulations.
Regulatory Compliance Framework
The compliance certificate was filed pursuant to Regulation 3(5) and 3(6) of Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015. Company Secretary and Sr Vice President Abhay Raj Singh, serving as the Compliance Officer, certified the company's full compliance with SDD requirements.
Key Compliance Parameters
The certificate confirms IOL Chemicals and Pharmaceuticals Limited meets all essential SDD requirements:
| Compliance Parameter | Status |
|---|---|
| Structured Digital Database in place | ✓ Compliant |
| Access controls implemented | ✓ Compliant |
| UPSI capture in database | ✓ Compliant |
| Nature, date and time recording | ✓ Compliant |
| Internal maintenance with audit trail | ✓ Compliant |
| Non-tamperable system with 8-year retention | ✓ Compliant |
Event Tracking and Performance
During the quarter ended 31st March 2026, the company was required to capture 1 event and successfully recorded 1 event, achieving 100.00% compliance rate. This demonstrates effective implementation of the company's insider trading prevention mechanisms.
Non-Compliance Status
The compliance certificate reported zero non-compliance issues for the quarter:
| Sr. No. | Particulars of noncompliance | Remedial action |
|---|---|---|
| - | Nil | N/a |
Corporate Governance Excellence
The timely submission of the SDD compliance certificate reflects IOL Chemicals and Pharmaceuticals Limited's commitment to maintaining high standards of corporate governance and regulatory compliance. The company's robust internal control systems ensure proper handling of Unpublished Price Sensitive Information (UPSI) and adherence to SEBI's insider trading prevention framework.
The certificate was digitally signed and submitted from the company's Ludhiana office, maintaining transparency in corporate communications with stock exchanges and regulatory authorities.
Historical Stock Returns for IOL Chemicals & Pharmaceuticals
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +1.08% | +12.99% | +27.96% | 0.0% | +41.23% | -22.23% |
Will SEBI introduce more stringent SDD requirements or additional compliance parameters for pharmaceutical companies in the upcoming regulatory review cycle?
How might IOL Chemicals' strong compliance track record influence investor confidence and institutional investment decisions in the next quarter?
Could the company's robust insider trading prevention mechanisms provide a competitive advantage when pursuing strategic partnerships or acquisitions?

































